Summary

HNY Research projects that the Chronic Kidney Disease Drugs market size will grow from 11697.27 Million USD in 2025 to 13286.35 Million USD by 2031, at an estimated CAGR of 2.15%. The base year considered for the study is 2025, and the market size is projected from 2026 to 2031.This report presents a detailed and holistic analysis of the global Chronic Kidney Disease Drugs market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Chronic Kidney Disease Drugs manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.

By Market Players:
Keryx Biopharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
AbbVie
GlaxoSmithKline
Sanofi
F. Hoffmann-La Roche Ltd
Pfizer
AstraZeneca
Amgen
Teva Pharmaceutical Industries

By Type
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others

By Application
Hospitals
Specialty Clinics

By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chronic Kidney Disease Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Chronic Kidney Disease Drugs Market Size Growth Rate by Type: 2026-2031
1.4.2 ACE Inhibitors
1.4.3 Calcium Channel Blockers
1.4.4 Beta Blockers
1.4.5 Others
1.5 Market by Application
1.5.1 Global Chronic Kidney Disease Drugs Market Share by Application: 2026-2031
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.6 Study Objectives
1.7 Overview of Global Chronic Kidney Disease Drugs Market
1.7.1 Global Chronic Kidney Disease Drugs Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 Manufacturing Cost Structure Analysis
2.1 Manufacturing Cost Structure Analysis of Chronic Kidney Disease Drugs
2.2 Industry Chain Structure of Chronic Kidney Disease Drugs
3 Market Competition by Manufacturers
3.1 Global Chronic Kidney Disease Drugs Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Chronic Kidney Disease Drugs Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Chronic Kidney Disease Drugs Average Price by Manufacturers (2020-2025)
4 Chronic Kidney Disease Drugs Regional Market Analysis
4.1 Chronic Kidney Disease Drugs Production by Regions
4.1.1 Global Chronic Kidney Disease Drugs Production by Regions (2020-2025)
4.1.2 Global Chronic Kidney Disease Drugs Revenue by Regions
4.2 Chronic Kidney Disease Drugs Consumption by Regions
4.3 North America Chronic Kidney Disease Drugs Market Analysis
4.3.1 North America Chronic Kidney Disease Drugs Production
4.3.2 North America Chronic Kidney Disease Drugs Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Chronic Kidney Disease Drugs Import and Export
4.4 East Asia Chronic Kidney Disease Drugs Market Analysis
4.4.1 East Asia Chronic Kidney Disease Drugs Production
4.4.2 East Asia Chronic Kidney Disease Drugs Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Chronic Kidney Disease Drugs Import & Export
4.5 Europe Chronic Kidney Disease Drugs Market Analysis
4.5.1 Europe Chronic Kidney Disease Drugs Production
4.5.2 Europe Chronic Kidney Disease Drugs Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Chronic Kidney Disease Drugs Import & Export
4.6 South Asia Chronic Kidney Disease Drugs Market Analysis
4.6.1 South Asia Chronic Kidney Disease Drugs Production
4.6.2 South Asia Chronic Kidney Disease Drugs Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Chronic Kidney Disease Drugs Import & Export
4.7 Southeast Asia Chronic Kidney Disease Drugs Market Analysis
4.7.1 Southeast Asia Chronic Kidney Disease Drugs Production
4.7.2 Southeast Asia Chronic Kidney Disease Drugs Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Chronic Kidney Disease Drugs Import & Export
4.8 Middle East Chronic Kidney Disease Drugs Market Analysis
4.8.1 Middle East Chronic Kidney Disease Drugs Production
4.8.2 Middle East Chronic Kidney Disease Drugs Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Chronic Kidney Disease Drugs Import & Export
4.9 Africa Chronic Kidney Disease Drugs Market Analysis
4.9.1 Africa Chronic Kidney Disease Drugs Production
4.9.2 Africa Chronic Kidney Disease Drugs Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Chronic Kidney Disease Drugs Import & Export
4.10 Oceania Chronic Kidney Disease Drugs Market Analysis
4.10.1 Oceania Chronic Kidney Disease Drugs Production
4.10.2 Oceania Chronic Kidney Disease Drugs Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Chronic Kidney Disease Drugs Import & Export
4.11 South America Chronic Kidney Disease Drugs Market Analysis
4.11.1 South America Chronic Kidney Disease Drugs Production
4.11.2 South America Chronic Kidney Disease Drugs Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Chronic Kidney Disease Drugs Import & Export
5 Chronic Kidney Disease Drugs Sales Market by Type (2020-2031)
5.1 Global Chronic Kidney Disease Drugs Historic Market Size by Type (2020-2025)
5.2 Global Chronic Kidney Disease Drugs Forecasted Market Size by Type (2026-2031)
6 Chronic Kidney Disease Drugs Consumption Market by Application(2020-2031)
6.1 Global Chronic Kidney Disease Drugs Historic Market Size by Application (2020-2025)
6.2 Global Chronic Kidney Disease Drugs Forecasted Market Size by Application (2026-2031)
7 Company Profiles and Key Figures in Chronic Kidney Disease Drugs Business
7.1 Keryx Biopharmaceuticals, Inc
7.1.1 Keryx Biopharmaceuticals, Inc Company Profile
7.1.2 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Product Specification
7.1.3 Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 Kissei Pharmaceutical Co., Ltd
7.2.1 Kissei Pharmaceutical Co., Ltd Company Profile
7.2.2 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Product Specification
7.2.3 Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 AbbVie
7.3.1 AbbVie Company Profile
7.3.2 AbbVie Chronic Kidney Disease Drugs Product Specification
7.3.3 AbbVie Chronic Kidney Disease Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Profile
7.4.2 GlaxoSmithKline Chronic Kidney Disease Drugs Product Specification
7.4.3 GlaxoSmithKline Chronic Kidney Disease Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Sanofi
7.5.1 Sanofi Company Profile
7.5.2 Sanofi Chronic Kidney Disease Drugs Product Specification
7.5.3 Sanofi Chronic Kidney Disease Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 F. Hoffmann-La Roche Ltd
7.6.1 F. Hoffmann-La Roche Ltd Company Profile
7.6.2 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Product Specification
7.6.3 F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.7 Pfizer
7.7.1 Pfizer Company Profile
7.7.2 Pfizer Chronic Kidney Disease Drugs Product Specification
7.7.3 Pfizer Chronic Kidney Disease Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.8 AstraZeneca
7.8.1 AstraZeneca Company Profile
7.8.2 AstraZeneca Chronic Kidney Disease Drugs Product Specification
7.8.3 AstraZeneca Chronic Kidney Disease Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.9 Amgen
7.9.1 Amgen Company Profile
7.9.2 Amgen Chronic Kidney Disease Drugs Product Specification
7.9.3 Amgen Chronic Kidney Disease Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.10 Teva Pharmaceutical Industries
7.10.1 Teva Pharmaceutical Industries Company Profile
7.10.2 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Product Specification
7.10.3 Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 Production and Supply Forecast
8.1 Global Forecasted Production of Chronic Kidney Disease Drugs (2026-2031)
8.2 Global Forecasted Revenue of Chronic Kidney Disease Drugs (2026-2031)
8.3 Global Forecasted Price of Chronic Kidney Disease Drugs (2020-2031)
8.4 Global Forecasted Production of Chronic Kidney Disease Drugs by Region (2026-2031)
8.4.1 North America Chronic Kidney Disease Drugs Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Chronic Kidney Disease Drugs Production, Revenue Forecast (2026-2031)
8.4.3 Europe Chronic Kidney Disease Drugs Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Chronic Kidney Disease Drugs Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Chronic Kidney Disease Drugs Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Chronic Kidney Disease Drugs Production, Revenue Forecast (2026-2031)
8.4.7 Africa Chronic Kidney Disease Drugs Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Chronic Kidney Disease Drugs Production, Revenue Forecast (2026-2031)
8.4.9 South America Chronic Kidney Disease Drugs Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Chronic Kidney Disease Drugs Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Chronic Kidney Disease Drugs by Application (2026-2031)
9 Consumption and Demand Forecast
9.1 North America Forecasted Consumption of Chronic Kidney Disease Drugs by Country
9.2 East Asia Market Forecasted Consumption of Chronic Kidney Disease Drugs by Country
9.3 Europe Market Forecasted Consumption of Chronic Kidney Disease Drugs by Countriy
9.4 South Asia Forecasted Consumption of Chronic Kidney Disease Drugs by Country
9.5 Southeast Asia Forecasted Consumption of Chronic Kidney Disease Drugs by Country
9.6 Middle East Forecasted Consumption of Chronic Kidney Disease Drugs by Country
9.7 Africa Forecasted Consumption of Chronic Kidney Disease Drugs by Country
9.8 Oceania Forecasted Consumption of Chronic Kidney Disease Drugs by Country
9.9 South America Forecasted Consumption of Chronic Kidney Disease Drugs by Country
9.10 Rest of the world Forecasted Consumption of Chronic Kidney Disease Drugs by Country
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer